Intravenous allogeneic multilineage-differentiating stress-enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open-label study
J Eur Acad Dermatol Venereol
.
2021 Aug;35(8):e528-e531.
doi: 10.1111/jdv.17201.
Epub 2021 Mar 14.
Authors
Y Fujita
1
2
,
T Nohara
1
,
S Takashima
1
,
K Natsuga
1
,
M Adachi
3
,
K Yoshida
3
,
S Shinkuma
4
,
T Takeichi
5
,
H Nakamura
1
,
O Wada
6
,
M Akiyama
5
,
A Ishiko
3
,
H Shimizu
1
Affiliations
1
Department of Dermatology, Hokkaido University Graduate School of Medicine and Faculty of Medicine, Sapporo, Japan.
2
Department of Dermatology, Sapporo City General Hospital, Sapporo, Japan.
3
Department of Dermatology, Toho University School of Medicine, Tokyo, Japan.
4
Department of Dermatology, Nara Medical University School of Medicine, Kashihara, Japan.
5
Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
6
Life Science Institute Inc., Tokyo, Japan.
PMID:
33656198
PMCID:
PMC8359848
DOI:
10.1111/jdv.17201
No abstract available
Publication types
Clinical Trial, Phase I
Clinical Trial, Phase II
Letter
MeSH terms
Adult
Epidermolysis Bullosa Dystrophica* / genetics
Epidermolysis Bullosa*
Hematopoietic Stem Cell Transplantation*
Humans
Skin
Grants and funding
joint research grant/Life Science Institute Inc.